Scientific MOOCs follower. Author of Airpocalypse, a techno-medical thriller (Spring 2017)

Welcome to the digital era of biology (and to this modest blog I started in early 2005).

To cure many diseases, like cancer or cystic fibrosis, we will need to target genes (mutations, for ex.), not organs! I am convinced that the future of replacement medicine (organ transplant) is genomics (the science of the human genome). In 10 years we will be replacing (modifying) genes; not organs!

Anticipating the $100 genome era and the P4™ medicine revolution. P4 Medicine (Predictive, Personalized, Preventive, & Participatory): Catalyzing a Revolution from Reactive to Proactive Medicine.

I am an early adopter of scientific MOOCs. I've earned myself four MIT digital diplomas: 7.00x, 7.28x1, 7.28.x2 and 7QBWx. Instructor of 7.00x: Eric Lander PhD.

Upcoming books: Airpocalypse, a medical thriller (action taking place in Beijing) 2017; Jesus CRISPR Superstar, a sci-fi -- French title: La Passion du CRISPR (2018).

I love Genomics. Would you rather donate your data, or... your vital organs? Imagine all the people sharing their data...

Audio files on this blog are Windows files ; if you have a Mac, you might want to use VLC ( to read them.

Concernant les fichiers son ou audio (audio files) sur ce blog : ce sont des fichiers Windows ; pour les lire sur Mac, il faut les ouvrir avec VLC (

The Journal of Genome Medicine

Genome Medicine leads the way as another 15 BioMed Central journals are tracked for Impact Factors.

Editor of Genome Medicine, Rebecca Furlong, said "We are delighted that Genome Medicine's success will be recognized with an Impact Factor, and would like to thank our Section Editors, Editorial Board, and all our authors, reviewers and readers for their support."

"Genome Medicine publishes peer-reviewed research articles, new methods and software tools in all areas of medicine studied from a post-genomic perspective. The journal also provides review and comment on the latest advances in translational genomics and personalized medicine, and their implications for the clinical and ethical management of human health and disease."

Genome Medicine leads the way in a long list of BioMed Central journals that have recently been accepted for Impact Factor tracking by Thomson Reuters. The newly tracked journals will soon appear on Web of Science, and should receive their first Impact Factors in June this year.

This is a whole new world to me, and a fascinating one...

Aucun commentaire: